Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Histiocytosis-X: an overview.

M E Osband1, C Pochedly

  • 1Boston City Hospital, Massachusetts.

Hematology/Oncology Clinics of North America
|March 1, 1987
PubMed
Summary

This overview discusses recurring themes in histiocytosis-X research, as featured in the Hematology/Oncology Clinics of North America. It highlights key areas of focus within this hematologic and oncologic condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Introduction.

Pediatric annals·2014
Same author

Introduction.

Pediatric annals·2014
Same author

Autolymphocyte therapy. III. Effective adjuvant adoptive cellular therapy with in vivo anti-tumor specificity against murine melanoma and carcinoma using ex-vivo-activated memory T-lymphocytes.

The Journal of surgical research·1995
Same author

Ex vivo activated memory T-lymphocytes as adoptive cellular therapy of human renal cell tumour targets with potentiation by cis-diamminedichloroplatinum(II).

British journal of urology·1995
Same author

Adoptive transfer of ex vivo-activated memory T-cell subsets with cyclophosphamide provides effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma.

International journal of cancer·1995
Same author

Ex vivo activated memory T-lymphocytes as adoptive cellular therapy of human soft-tissue sarcoma targets with potentiation by cis-diamminedichloroplatinum(II).

Journal of surgical oncology·1995

Area of Science:

  • Hematology
  • Oncology
  • Histiocytosis Research

Background:

  • Histiocytosis-X, now known as Langerhans cell histiocytosis (LCH), is a rare group of disorders.
  • Understanding the diverse clinical presentations and underlying mechanisms is crucial.

Purpose of the Study:

  • To provide a comprehensive overview of current research themes in histiocytosis-X.
  • To synthesize key findings and recurring topics within the Hematology/Oncology Clinics of North America issue.

Main Methods:

  • Review of articles and research presented in the specified issue.
  • Identification of common themes and research trends related to histiocytosis-X.

Main Results:

  • Several recurring themes were identified across the research presented.
  • The issue consolidates recent advancements and ongoing discussions in the field.

Conclusions:

  • The collected research offers valuable insights into histiocytosis-X.
  • This compilation serves as a significant resource for clinicians and researchers in hematology and oncology.

Related Experiment Videos